Download from app store
We have detected that you are using an Ad Blocker.
PracticeUpdate is free to end users but we rely on advertising to fund our site. Please consider supporting PracticeUpdate by whitelisting us in your ad blocker.
We have sent a message to the email address you have provided, . If this email is not correct, please update your settings with your correct address.
The email address you provided during registration, , does not appear to be valid. Please update your settings with a valid address before to continue using PracticeUpdate.
Please provide your AHPRA Number to ensure that you are given the correct level of access to our site.

Journal Scan / Research · April 09, 2024

Impact of Polypharmacy and Anticholinergic Medication on Objective Cognitive Performance in Adults With MS

International Journal of MS Care

 

Additional Info

Disclosure statements are available on the authors' profiles:

International Journal of MS Care
Investigating the Impact of Polypharmacy and Anticholinergic Medication Burden on Objective Cognitive Performance in Adults With Multiple Sclerosis
Int J MS Care 2024 Mar 01;26(2)81-88, J Huebner, J Robichaud, JS Cozart, C Burkhardt, SG Lynch, JM Bruce

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine.

Further Reading